0001517294-14-000001.txt : 20140417 0001517294-14-000001.hdr.sgml : 20140417 20140417093529 ACCESSION NUMBER: 0001517294-14-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140417 DATE AS OF CHANGE: 20140417 EFFECTIVENESS DATE: 20140417 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Annovation BioPharma, Inc. CENTRAL INDEX KEY: 0001517294 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-181765 FILM NUMBER: 14768857 BUSINESS ADDRESS: STREET 1: C/O ATLAS VENTURE STREET 2: 25 FIRST STREET, SUITE 303 CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: 617-588-2600 MAIL ADDRESS: STREET 1: C/O ATLAS VENTURE STREET 2: 25 FIRST STREET, SUITE 303 CITY: CAMBRIDGE STATE: MA ZIP: 02141 D/A 1 primary_doc.xml X0707 D/A LIVE 0001517294 Annovation BioPharma, Inc. C/O ATLAS VENTURE 25 FIRST STREET, SUITE 303 CAMBRIDGE MA MASSACHUSETTS 02141 617-588-2600 DELAWARE None None Corporation true 2009 David Grayzel c/o Atlas Venture 25 First Street, Suite 303 Cambridge MA MASSACHUSETTS 02141 Executive Officer Director Carl Berke c/o Atlas Venture 25 First Street, Suite 303 Cambridge MA MASSACHUSETTS 02141 Executive Officer Director Ankit Mahadevia c/o Atlas Venture 25 First Street, Suite 303 Cambridge MA MASSACHUSETTS 02141 Director Jean-Francois Formela c/o Atlas Venture 25 First Street, Suite 303 Cambridge MA MASSACHUSETTS 02141 Director Jason Campagna c/o Atlas Venture 25 First Street, Suite 303 Cambridge MA MASSACHUSETTS 02141 Director Pharmaceuticals Decline to Disclose 06b true 0001517294-12-000003 2012-07-23 false true false 0 11000201 8000201 3000000 false 10 0 0 0 false Annovation BioPharma, Inc. /s/ David Grayzel David Grayzel Secretary 2014-04-17